Cargando…
Vaccination COVID-19 : technologies vaccinales, efficacité en vie réelle et spécificités
The rapid development and accelerated evaluation of effective vaccines against SARS-CoV-2 have made it possible to partially control the COVID-19 pandemic, responsible for an unprecedented health crisis. In June 2022, six vaccines are authorized in Europe, eleven are recognized by the World Health O...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS on behalf of Société de pathologie infectieuse de langue française (SPILF).
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257089/ http://dx.doi.org/10.1016/j.mmifmc.2022.07.001 |